Memantine LEK
Země: Evropská unie
Jazyk: francouzština
Zdroj: EMA (European Medicines Agency)
Informace pro uživatele
(PIL)
16-11-2020
Charakteristika produktu
(SPC)
16-11-2020
Veřejná zpráva o hodnocení
(PAR)
29-04-2013
Aktivní složka:
chlorhydrate de mémantine
Dostupné s:
Pharmathen S.A.
ATC kód:
N06DX01
INN (Mezinárodní Name):
memantine
Terapeutické skupiny:
Psychoanaleptics, , d'Autres anti-démence médicaments
Terapeutické oblasti:
Maladie d'Alzheimer
Terapeutické indikace:
Traitement des patients atteints de la maladie d'Alzheimer modérée à sévère.
Přehled produktů:
Revision: 5
Stav Autorizace:
Autorisé
Datum autorizace:
2013-04-21
Informace pro uživatele
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Přečtěte si celý dokument
Charakteristika produktu
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Přečtěte si celý dokument
